Prostate cancer screening has changed: Here's what you dudes should know


Don't fear the finger. Guys who have been putting off prostate cancer screenings because they fear an uncomfortable exam, can have a PSA blood test that helps doctors identify those who may need additional testing.


by Tim Ditman
OSF Healthcare


John Rinker, MD, an internal medicine physician at OSF HealthCare, has a message for men: prostate cancer screenings are important, and you shouldn’t put them off over “fear of the finger.” In other words, fear that the exam will be uncomfortable. Dr. Rinker says technology and guidelines have evolved so that doctors can get a clear picture of what’s going on in a noninvasive way.


... prostate cancer largely comes with no symptoms, making screenings all the more important

The prostate: A recap
Dr. Rinker says the prostate is an organ that helps produce and protect sperm.

“It continues to grow over time in most men. Different parts of the prostate can start to have abnormal growths. The big concern is that prostate cancer can form. About one in eight men have a lifetime risk of developing prostate cancer,” Dr. Rinker explains. He adds that prostate cancer is the second-leading cause of cancer death in men.

Genetics, family history, old age, ethnicity, smoking and obesity put you at a higher risk. And Dr. Rinker adds that prostate cancer largely comes with no symptoms, making screenings all the more important. If you do have symptoms, those can mimic traits of an enlarged prostate, such as difficulty urinating, blood in semen or pain around the groin.

Screenings
Dr. Rinker says men should start talking to their primary care provider about prostate cancer screening at age 40. He says the method that most men know – a digital rectal exam – has actually fallen out of favor with medical professionals.

“We really didn’t find that the digital rectal exam was very effective,” Dr. Rinker opines. “There’s a lot of user bias with how well [a provider] is at examining. Maybe they won’t be able to detect a larger, late state lesion as well.”


Gustavo Fring/PEXELS

Men should begin talking with their primary care providers about prostate cancer screening at age 40, starting with the Prostate-Specific Antigen (PSA) test. Early detection can provide more treatment options and improve the chances of curing the disease.

Instead, the standard is a prostate-specific antigen (PSA) blood test. This measures the level of a protein produced by the prostate in your blood.

“It can be added to your routine bloodwork. Nothing more than that. It could save your life,” Dr. Rinker says.


Photo: Samia Javed/PEXELS

Early detection can mean more treatment options for men with prostate cancer. Doctors have new, less evasive prostate cancer screenings protocol at their disposal.

If the test finds elevated PSA levels, a provider might recommend a prostate MRI (magnetic resonance imaging). As the name suggests, this is noninvasive imaging that gives providers a clear picture of the organ.

“This can lead to a reduction in biopsies that are unnecessary,” Dr. Rinker says.

The bottom line
Dr. Rinker repeats advice that men have heard plenty: know your body, know your family history, choose healthy behaviors and see your provider regularly.

“The whole goal of [educating people on screenings] is catching cancer earlier. If you do that, you have more treatment options. You have a better chance to cure the cancer,” Dr. Rinker says. “In some cases if it’s a low-grade cancer, you may choose to not to treat it at all. We can monitor it. We can re-image it or utilize a PSA test to see if it changes.”


TAGGED: prostate cancer screening for Illinois men, PSA blood test prostate cancer screening, when men should start prostate cancer screening, OSF HealthCare prostate cancer screening advice, noninvasive prostate cancer screening options


Editor's Choice


A pair of penalty kicks lift Michigan past Illinois in Big Ten match

Michigan made the most of its limited scoring opportunities Sunday, converting two penalty kicks to defeat Illinois 2-0 a...


More Sentinel Stories